Meet the Team
Founder & CEO
Stanford PhD, Co-inventor, Decade of experience with mRNA for therapeutic applications. Thesis title: Telomere extension to extend human healthspan.
Founder & COO
Stanford PhD, Decade of experience in genetics and epigenetics of cellular reprogramming.
VP Preclinical Development
PHD, MBA, Led two startups from bench to clinic and aquisition, respectively.
MD, MSc, PhD, CTBS, Clinical and Preclinical Development at Boehringer Ingelheim and Gilead. Postdoc at Yale University on novel roles of ion transport proteins.
Postdoc at Stanford University on the proteomics of aging in the liver and brain, PhD in Biophysics at UT Southwestern on neurotransmitter release.
Life Science Research Associate
MSc in Biotechnology
11 years as Director of Manufacturing at Arbutus precursor Tekmira, Biologics CMC head at Nitto Denko, multiple other companies
Bioengineering Research Associate
BSc in Bioengineering
Life Science Research Associate II
BSc in Cell and Molecular Biology
Director of Finance and Administration
Stanford AB in Cultural Anthropology, 30+ years of F&A experience supporting research excellence at Stanford School of Medicine.
MD, PhD, MBA
Seasoned pharma veteran, 5 $B+ drugs
DABT, ex-FDA/CBER/Covance, Toxicology & Regulatory Advisor, Pfizer COVID mRNA vaccine consultant
Led Pirfenidone approval, entrepreneur, fibrotic disease expert
Founder & Advisor
Co-inventor, Professor at Stanford University, discovered that short telomeres underlie the fatal etiology of multiple monogenic diseases.
>100 INDs as the founder of the first biologics translational department at City of Hope, Los Angeles
Professor and Chair Pulmonary Medicine at Cedars Sinai, Leading Clinician-Researcher in IPF